1,001
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Enhancing oral bioavailability of andrographolide using solubilizing agents and bioenhancer: comparative pharmacokinetics of Andrographis paniculata formulations in beagle dogs

, , , , , & show all
Pages 183-194 | Received 12 Jul 2023, Accepted 23 Jan 2024, Published online: 13 Feb 2024

References

  • Bahr MN, Modi D, Patel S, Campbell G, Stockdale G. 2019. Understanding the role of sodium lauryl sulfate on the biorelevant solubility of a combination of poorly water-soluble drugs using high throughput experimentation and mechanistic absorption modeling. J Pharm Pharm Sci. 22(1):221–246. doi:10.18433/jpps30347.
  • Bera R, Ahmed SK, Sarkar L, Sen T, Karmakar S. 2014. Pharmacokinetic analysis and tissue distribution of andrographolide in rat by a validated LC-MS/MS method. Pharm Biol. 52(3):321–329. doi:10.3109/13880209.2013.836544.
  • Boonyarattanasoonthorn T, Kongratanapasert T, Maiuthed A, Hamlin R, Kijtawornrat A, Khemawoot P. 2022. Bioenhancing effects of piperine and curcumin on triterpenoid pharmacokinetics and neurodegenerative metabolomes from Centella asiatica extract in beagle dogs. Sci Rep. 12(1):20789. doi:10.1038/s41598-022-24935-7.
  • Brewster ME, Loftsson T. 2007. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 59(7):645–666. doi:10.1016/j.addr.2007.05.012.
  • Chao WW, Lin BF. 2010. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med. 5(1):17. doi:10.1186/1749-8546-5-17.
  • Cheung HY, Cheung CS, Kong CK. 2001. Determination of bioactive diterpenoids from Andrographis paniculata by micellar electrokinetic chromatography. J Chromatogr A. 930(1–2):171–176. doi:10.1016/s0021-9673(01)01160-8.
  • Chokwarakul C. 2021. Local herbs against COVID-19 virus. In: Proceedings of RSU International Research Conference 2021. Pathum Thani, Thailand: Rangsit University.
  • Dudhatra GB, Mody SK, Awale MM, Patel HB, Modi CM, Kumar A, Kamani DR, Chauhan BN. 2012. A comprehensive review on pharmacotherapeutics of herbal bioenhancers. Sci World J. 2012:637953–637933. doi:10.1100/2012/637953.
  • Elder R. 1983. Final report on the safety assessment of sodium lauryl sulfate and ammonium lauryl sulfate. J Am Coll Toxicol. 2:127–181.
  • [EMA] European Medicines Agency. 2017a. Cyclodextrins used as excipients report published in support of the ‘questions and answers on cyclodextrins used as excipients in medicinal products for human use’ (EMA/CHMP/495747/2013). London (UK): EMA. [accessed 2023 Mar 2]. https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-cyclodextrins-used-excipients-medicinal-products-human-use_en.pdf.
  • [EMA] European Medicines Agency. 2017b. Sodium laurilsulfate used as an excipient report published in support of the’questions and answers on sodium laurilsulfate used as an excipient in medicinal products for human use’ (EMA/CHMP/606830/2017). London (UK): EMA. [accessed 2023 Mar 2]. https://www.ema.europa.eu/en/documents/report/sodium-laurilsulfate-used-excipient-report-published-support-questions-answers-sodium-laurilsulfate_en.pdf.
  • Han Y, Chin Tan TM, Lim LY. 2008. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicol Appl Pharmacol. 230(3):283–289. doi:10.1016/j.taap.2008.02.026.
  • [ICH] International Council for Harmonization. 2019. ICH guideline M10 on bioanalytical method validation. ICH. [accessed 2023 Mar 2]. https://database.ich.org/sites/default/files/M10_Guideline_Step4_2022_0524.pdf.
  • Intharuksa A, Arunotayanun W, Yooin W, Sirisa-Ard P. 2022. A comprehensive review of Andrographis paniculata (Burm. f.) Nees and its constituents as potential lead compounds for COVID-19 drug discovery. Molecules. 27(14):4479. doi:10.3390/molecules27144479.
  • Jarukamjorn K, Nemoto N. 2008. Pharmacological aspects of Andrographis paniculata on health and its major diterpenoid constituent andrographolide. J Health Sci. 54(4):370–381. doi:10.1248/jhs.54.370.
  • Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N. 2011. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 55(8):1169–1176. doi:10.1002/mnfr.201100117.
  • Junsaeng D, Anukunwithaya T, Songvut P, Sritularak B, Likhitwitayawuid K, Khemawoot P. 2019. Comparative pharmacokinetics of oxyresveratrol alone and in combination with piperine as a bioenhancer in rats. BMC Complement Altern Med. 19(1):235. doi:10.1186/s12906-019-2653-y.
  • Lee SY, Abdullah LC, Rahman RA, Abas F, Chong GH. 2019. Role of polymers as crystal growth inhibitors in coprecipitation via solution-enhanced dispersion by supercritical fluids (SEDS) to improve andrographolide dissolution from standardized Andrographis paniculata extract. J Drug Deliv Sci Technol. 50:145–154. doi:10.1016/j.jddst.2019.01.026.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46(1–3):3–26. doi:10.1016/s0169-409x(00)00129-0.
  • Loureiro Damasceno JP, Silva da Rosa H, Silva de Araújo L, Jacometti Cardoso Furtado NA. 2022. Andrographis paniculata formulations: impact on diterpene lactone oral bioavailability. Eur J Drug Metab Pharmacokinet. 47(1):19–30. doi:10.1007/s13318-021-00736-7.
  • Mehta S, Sharma AK, Singh RK. 2021. Pharmacological activities and molecular mechanisms of pure and crude extract of Andrographis paniculata: an update. Phytomedicine Plus. 1(4):100085. 100085. doi:10.1016/j.phyplu.2021.100085.
  • Naik SR, Hule A. 2009. Evaluation of immunomodulatory activity of an extract of andrographolides from Andographis paniculata. Planta Med. 75(8):785–791. doi:10.1055/s-0029-1185398.
  • Pandey G, Rao C. 2018. Andrographolide: its pharmacology, natural bioavailability and current approaches to increase its content in Andrographis paniculata. Int J Complement Alt Med. 11:355–360.
  • Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G, Wagner H. 2000. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine. 7(5):351–364. doi:10.1016/S0944-7113(00)80054-9.
  • Pholphana N, Panomvana D, Rangkadilok N, Suriyo T, Puranajoti P, Ungtrakul T, Pongpun W, Thaeopattha S, Songvut P, Satayavivad J. 2016. Andrographis paniculata: dissolution investigation and pharmacokinetic studies of four major active diterpenoids after multiple oral dose administration in healthy Thai volunteers. J Ethnopharmacol. 194:513–521. doi:10.1016/j.jep.2016.09.058.
  • Pholphana N, Rangkadilok N, Saehun J, Ritruechai S, Satayavivad J. 2013. Changes in the contents of four active diterpenoids at different growth stages in Andrographis paniculata (Burm.f.) Nees (Chuanxinlian). Chin Med. 8(1):2. doi:10.1186/1749-8546-8-2.
  • Rowe R, Sheskey P, Owen S. 2006. Handbook of pharmaceutical excipients. London (UK): Pharmaceutical Press.
  • Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, Charoensutthivarakul S, Wongtrakoongate P, Pitiporn S, Chaopreecha J, et al. 2021. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod. 84(4):1261–1270. doi:10.1021/acs.jnatprod.0c01324.
  • Saokham P, Muankaew C, Jansook P, Loftsson T. 2018. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 23(5):1161. doi:10.3390/molecules23051161.
  • Song Y-X, Liu S-P, Jin Z, Qin J-F, Jiang Z-Y. 2013. Qualitative and quantitative analysis of Andrographis paniculata by rapid resolution liquid chromatography/time-of-flight mass spectrometry. Molecules. 18(10):12192–12207. 10.3390/molecules181012192.24084022.
  • Songvut P, Pholphana N, Suriyo T, Rangkadilok N, Panomvana D, Puranajoti P, Satayavivad J. 2023. A validated LC–MS/MS method for clinical pharmacokinetics and presumptive phase II metabolic pathways following oral administration of Andrographis paniculata extract. Sci Rep. 13(1):2534. doi:10.1038/s41598-023-28612-1.
  • Songvut P, Suriyo T, Panomvana D, Rangkadilok N, Satayavivad J. 2022. A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease. Front Pharmacol. 13:952660. 952660. doi:10.3389/fphar.2022.952660.
  • Tanwettiyanont J, Piriyachananusorn N, Sangsoi L, Boonsong B, Sunpapoa C, Tanamatayarat P, Na-Ek N, Kanchanasurakit S. 2022. Use of Andrographis paniculata (Burm.f.) Wall. ex Nees and risk of pneumonia in hospitalised patients with mild coronavirus disease 2019: a retrospective cohort study. Front Med (Lausanne). 9:947373. 947373. doi:10.3389/fmed.2022.947373.
  • [USFDA] U.S. Food and Drug Administration. 2018. Guidance for industry: bioanalytical method validation. Maryland (MD): U.S. Department of Health and Human Services, Food and Drug Administration. [accessed 2023 Mar 2]. https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf.
  • Wang Y, Jiao J, Yang Y, Yang M, Zheng Q. 2018. Screening and identification for immunological active components from Andrographis Herba using macrophage biospecific extraction coupled with UPLC/Q-TOF-MS. Molecules. 23(5):1047. doi:10.3390/molecules23051047.
  • [WHO] World Health Organization. 2002. WHO monographs on selected medicinal plants. Geneva (Switzerland): World Health Organization. Vol. 2:12–24.
  • Xu FF, Fu SJ, Gu SP, Wang ZM, Wang ZZ, He X, Xiao W. 2015. Simultaneous determination of andrographolide, dehydroandrographolide and neoandrographolide in dog plasma by LC-MS/MS and its application to a dog pharmacokinetic study of Andrographis paniculata tablet. J Chromatogr B Anal Technol Biomed Life Sci. 990:125–131. doi:10.1016/j.jchromb.2015.03.014.
  • Yang T, Xu C, Wang ZT, Wang CH. 2013. Comparative pharmacokinetic studies of andrographolide and its metabolite of 14-deoxy-12-hydroxy-andrographolide in rat by ultra-performance liquid chromatography-mass spectrometry. Biomed Chromatogr. 27(7):931–937. doi:10.1002/bmc.2884.
  • Ye L, Wang T, Tang L, Liu W, Yang Z, Zhou J, Zheng Z, Cai Z, Hu M, Liu Z. 2011. Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P‐glycoprotein. J Pharm Sci. 100(11):5007–5017. doi:10.1002/jps.22693.
  • Zeng B, Wei A, Zhou Q, Yuan M, Lei K, Liu Y, Song J, Guo L, Ye Q. 2022. Andrographolide: a review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches. Phytother Res. 36(1):336–364. doi:10.1002/ptr.7324.
  • Zeng X, Cai D, Zeng Q, Chen Z, Zhong G, Zhuo J, Gan H, Huang X, Zhao Z, Yao N, et al. 2017. Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat. Biopharm Drug Dispos. 38(1):3–19. doi:10.1002/bdd.2049.
  • Zhao Y, Kao CP, Wu KC, Liao CR, Ho YL, Chang YS. 2014. Chemical compositions, chromatographic fingerprints and antioxidant activities of Andrographis Herba. Molecules. 19(11):18332–18350. doi:10.3390/molecules191118332.
  • Zou L, Ding W, Huang Q, Yang X, Li J, Huang T, Li Z, Lin S, Feng J. 2022. Andrographolide/phospholipid/cyclodextrin complex-loaded nanoemulsion: preparation, optimization, in vitro and in vivo evaluation. Biol Pharm Bull. 45(8):1106–1115. doi:10.1248/bpb.b22-00154.